These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 11260274

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study.
    Kreuz W, Escuriola Ettingshausen C, Vdovin V, Zozulya N, Plyushch O, Svirin P, Andreeva T, Bubanská E, Campos M, Benedik-Dolničar M, Jiménez-Yuste V, Kitanovski L, Klukowska A, Momot A, Osmulskaya N, Prieto M, Šalek SZ, Velasco F, Pavlova A, Oldenburg J, Knaub S, Jansen M, Belyanskaya L, Walter O, ObsITI study group, ObsITI committee.
    Haemophilia; 2016 Jan; 22(1):87-95. PubMed ID: 26202305
    [Abstract] [Full Text] [Related]

  • 3. Prompt immune tolerance induction at inhibitor diagnosis regardless of titre may increase overall success in haemophilia A complicated by inhibitors: experience of two U.S. centres.
    Nakar C, Manco-Johnson MJ, Lail A, Donfield S, Maahs J, Chong Y, Blades T, Shapiro A.
    Haemophilia; 2015 May; 21(3):365-373. PubMed ID: 25581638
    [Abstract] [Full Text] [Related]

  • 4. Successful low dose immune tolerance induction in severe haemophilia A with inhibitors below 40 Bethesda Units.
    Ter Avest PC, Fischer K, Gouw SC, Van Dijk K, Mauser-Bunschoten EP.
    Haemophilia; 2010 May; 16(102):71-9. PubMed ID: 20536988
    [Abstract] [Full Text] [Related]

  • 5. Immune tolerance in hemophilia-principal results from the International Registry. Report of the factor VIII and IX Subcommittee.
    Mariani G, Ghirardini A, Bellocco R.
    Thromb Haemost; 1994 Jul; 72(1):155-8. PubMed ID: 7974364
    [Abstract] [Full Text] [Related]

  • 6. The North American Immune Tolerance Registry: practices, outcomes, outcome predictors.
    DiMichele DM, Kroner BL, North American Immune Tolerance Study Group.
    Thromb Haemost; 2002 Jan; 87(1):52-7. PubMed ID: 11848456
    [Abstract] [Full Text] [Related]

  • 7. Immune tolerance for haemophilia patients with inhibitors: analysis of the western United States experience. The Tri-Regional Nursing Group.
    Damiano ML, Hutter JJ.
    Haemophilia; 2000 Sep; 6(5):526-32. PubMed ID: 11012697
    [Abstract] [Full Text] [Related]

  • 8. Frequency of factor VIII (FVIII) inhibitor in haemophilia A.
    Borhany M, Kumari M, Shamsi T, Naz A, Farzana T.
    J Coll Physicians Surg Pak; 2012 May; 22(5):289-93. PubMed ID: 22538032
    [Abstract] [Full Text] [Related]

  • 9. Zero incidence of inhibitors in previously untreated patients who received intermediate purity factor VIII concentrate or factor IX complex.
    Schimpf K, Schwarz P, Kunschak M.
    Thromb Haemost; 1995 Mar; 73(3):553-5. PubMed ID: 7667845
    [No Abstract] [Full Text] [Related]

  • 10. Immune tolerance induction in the treatment of paediatric haemophilia A patients with factor VIII inhibitors.
    Unuvar A, Warrier I, Lusher JM.
    Haemophilia; 2000 May; 6(3):150-7. PubMed ID: 10792472
    [Abstract] [Full Text] [Related]

  • 11. The long-term course of factor VIII inhibitors in patients with congenital haemophilia A without immune tolerance induction.
    Caram C, de Souza RG, de Sousa JC, Araújo Pereira T, do Amaral Cerqueira AM, van der Bom JG, Rezende SM.
    Thromb Haemost; 2011 Jan; 105(1):59-65. PubMed ID: 21057702
    [Abstract] [Full Text] [Related]

  • 12. Inhibitors in haemophilia: a primer.
    DiMichele DM.
    Haemophilia; 2000 Jul; 6 Suppl 1():38-40. PubMed ID: 10982266
    [No Abstract] [Full Text] [Related]

  • 13. Immune tolerance in children with factors VIII and IX inhibitors: a single centre experience.
    Mathias M, Liesner R, Hann I, Khair K.
    Haemophilia; 2005 Jul; 11(4):340-5. PubMed ID: 16011585
    [Abstract] [Full Text] [Related]

  • 14. Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization.
    Collins PW, Chalmers E, Hart DP, Liesner R, Rangarajan S, Talks K, Williams M, Hay CR, UK Haemophilia Centre Doctors.
    Br J Haematol; 2013 Jan; 160(2):153-70. PubMed ID: 23157203
    [No Abstract] [Full Text] [Related]

  • 15. Inhibitors in haemophilia A: current management and open issues.
    Haya S, Moret A, Cid AR, Cortina V, Casaña P, Cabrera N, Aznar JA.
    Haemophilia; 2007 Dec; 13 Suppl 5():52-60. PubMed ID: 18078398
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Immune tolerance induction in haemophilia A patients with inhibitors by treatment with recombinant factor VIII: a retrospective non-interventional study.
    Rivard GE, Rothschild C, Toll T, Achilles K.
    Haemophilia; 2013 May; 19(3):449-55. PubMed ID: 23510123
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Risk of the appearance of inhibitors linked to the administration of factors VIII and IX. Review of the literature].
    Calvez T, Costagliola D.
    Transfus Clin Biol; 1994 May; 1(6):427-35. PubMed ID: 7881588
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.